These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 1865207)

  • 1. Vigabatrin and psychosis.
    Sander JW; Hart YM; Trimble MR; Shorvon SD
    J Neurol Neurosurg Psychiatry; 1991 May; 54(5):435-9. PubMed ID: 1865207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vigabatrin-associated reversible acute psychosis in a child.
    Cánovas Martínez A; Ordovás Baines JP; Beltrán Marqués M; Escrivá Aparisi A; Delgado Cordón F
    Ann Pharmacother; 1995 Nov; 29(11):1115-7. PubMed ID: 8573955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamma-vinyl GABA (vigabatrin): relationship between dosage, plasma concentrations, platelet GABA-transaminase inhibition, and seizure reduction in epileptic children.
    Arteaga R; Herranz JL; Valdizán EM; Armijo JA
    Epilepsia; 1992; 33(5):923-31. PubMed ID: 1396437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute psychosis and vigabatrin in childhood].
    Chiaretti A; Castorina M; Tortorolo L; Piastra M; Polidori G
    Pediatr Med Chir; 1994; 16(5):489-90. PubMed ID: 7885961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vigabatrin.
    Lancet; 1989 Mar; 1(8637):532-3. PubMed ID: 2564063
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term antiepileptic efficacy of vigabatrin in drug-refractory epilepsy in mentally retarded patients. A 5-year follow-up study.
    Pitkänen A; Ylinen A; Matilainen R; Luukkainen R; Mervaala E; Seppänen R; Ruutiainen T; Riekkinen PJ
    Arch Neurol; 1993 Jan; 50(1):24-9. PubMed ID: 8418797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vigabatrin and psychosis.
    Brodie MJ; McKee PJ
    Lancet; 1990 May; 335(8700):1279. PubMed ID: 1971344
    [No Abstract]   [Full Text] [Related]  

  • 8. Vigabatrin in epilepsy in mentally retarded patients.
    Matilainen R; Pitkänen A; Ruutiainen T; Mervaala E; Riekkinen P
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):113S-118S. PubMed ID: 2757902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vigabatrin and behaviour disturbances.
    Sander JW; Hart YM
    Lancet; 1990 Jan; 335(8680):57. PubMed ID: 1967367
    [No Abstract]   [Full Text] [Related]  

  • 10. Psychiatric symptoms after therapy with new antiepileptic drugs: psychopathological and seizure related variables.
    Trimble MR; Rüsch N; Betts T; Crawford PM
    Seizure; 2000 Jun; 9(4):249-54. PubMed ID: 10880283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vigabatrin: a three year clinical analysis.
    Martin PJ; Millac PA
    Seizure; 1993 Jun; 2(2):137-40. PubMed ID: 8167965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vigabatrin in the treatment of epilepsy in children.
    Livingston JH; Beaumont D; Arzimanoglou A; Aicardi J
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):109S-112S. PubMed ID: 2757901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of vigabatrin as an add-on drug in the management of severe epilepsy.
    Sander JW; Trevisol-Bittencourt PC; Hart YM; Shorvon SD
    J Neurol Neurosurg Psychiatry; 1990 Nov; 53(11):1008-10. PubMed ID: 2283513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bipolar affective psychosis after vigabatrin.
    Naumann M; Supprian T; Kornhuber J; Lange KW; Reiners K
    Lancet; 1994 Mar; 343(8897):606-7. PubMed ID: 7906364
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute encephalopathy with vigabatrin.
    Sälke-Kellermann A; Baier H; Rambeck B; Boenigk HE; Wolf P
    Lancet; 1993 Jul; 342(8864):185. PubMed ID: 8101289
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacology of vigabatrin.
    Sabers A; Gram L
    Pharmacol Toxicol; 1992 Apr; 70(4):237-43. PubMed ID: 1608908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vigabatrin-induced forced normalization and psychosis--prolongated termination of behavioral symptoms but persistent antiepileptic effect after withdrawal.
    Weber P; Dill P; Datta AN
    Epilepsy Behav; 2012 May; 24(1):138-40. PubMed ID: 22503470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Six-year follow-up study on the efficacy and safety of vigabatrin in patients with epilepsy.
    Tartara A; Manni R; Galimberti CA; Morini R; Mumford JP; Iudice A; Perucca E
    Acta Neurol Scand; 1992 Sep; 86(3):247-51. PubMed ID: 1414241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of vigabatrin in the long-term treatment of refractory epilepsy.
    Remy C; Beaumont D
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):125S-129S. PubMed ID: 2757903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alternative Psychoses and Forced Normalization after Seizure Control by Anticonvulsants with Special Consideration of the New Anticonvulsants].
    Fröscher W; Steinert T
    Fortschr Neurol Psychiatr; 2020 May; 88(5):307-317. PubMed ID: 30786318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.